Plunkett Research Online: Neurobiological Technologies Inc

NEUROBIOLOGICAL TECHNOLOGIES INC (NTII:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Neurobiological Technologies, Inc. is focused on developing novel, first-in-class treatments for central nervous system conditions and other serious unmet medical needs. The company's most advanced product candidate, Viprinex'TM', is in Phase 3 clinical testing as a novel investigational drug for t.....



Neurobiological Technologies Inc
Ticker: NTII
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 510 595-6000
Fax: 510 262-0204
Address: 2000 Powell Street
Suite 800
Emeryville, CA 94608 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
Matthew LoarCFO/Director/Vice President
Abraham CohenChairman of the Board/Director
See More
Neurobiological Technologies, Inc. is focused on developing novel, first-in-class treatments for central nervous system conditions and other serious unmet medical needs. The company's most advanced product candidate, Viprinex'TM', is in Phase 3 clinical testing as a novel investigational drug for t.....See More See More

Auditor: OUM & Co. LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2009
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: